Dr Suneel Talwar

MBBS, MRCP (UK), MD (UK)


Profile

Dr Talwar started his specilisation in cardiology in Leicester in 1996 and was subsequently granted a research fellowship by Leicester University in 1997.  He then moved to the South West Cardiothoracic Centre, Plymouth in 1999 where he spent 5 years as a Specialist Register in Cardiology.  In 2003-04 he spend time as an international fellow at the St Olav University Hospital, Trondheim, Norway.

He was appointed as the clinical lead for the Coronary Angioplasty programme at the Royal Bournemouth Hospital in 2005.  In addition to general cardiology his main interest is in complex coronary intervention.


Clinics

  • Tuesday from 3pm
  • Friday from 11am
  • Weekly

Locations

Current posts

  • PCI Lead and Consultant Interventional Cardiologist, Royal Bournemouth Hospital

Interests

Specialising in all aspects of general and interventional cardiology including coronary angiography, PCI (Percutaneous Coronary Intervention, commonly known as coronary angioplasty and stenting) as well as the treatment of valvular heart disease, heart failure, hypertension and atrial fibrillation.


Other interests

Dr Talwar has a particular interest in complex intervention. He is a national proctor for rotational atherectomy in the UK. He is a European proctor for laser atherectomy and has trained over 100 physicians from the UK and Europe in this new and exciting technique. He also has a particular interest in complex chronic total occlusion PCI and receives referrals from several hospitals south of London including Salisbury, Southampton, Basingstoke and Winchester.

Personal interests

Walking, travelling and playing snooker.


Member of

  • British Cardiovascular Interventional Society

Research

Clinical events after deferral of LAD Revascularization following Physiological Coronary Assessment. J Am Coll Cardiol. 2019 Feb 5;73(4).

Randomised comparison of a biodegradable polymer ultra-thin sirolimus-eluting stent versus a durable polymer everolimus-eluting stent in patients with de novo native coronary artery lesions: the meriT-V trial. EuroIntervention. 2018 Dec 7;14(11):e1207-e1214.

ORBITA investigators.Percutaneous coronary intervention in stable angina (ORBITA): a double-blind randomised controlled trial. Lancet. 2018 Jan 6;391(10115):31-40. doi: 10.1016/S0140-6736(17)32714-9.

Polymer-Free Drug-Coated Coronary Stents Are Cost-Effective in Patients at High Bleeding Risk: Economic Evaluation of the LEADERS FREE Trial. EuroIntervention.2018 Feb 20;13(14):1688-1695. .

Safety and Efficacy of Polymer-Free Biolimus A9-Coated Versus Bare-Metal Stents in Orally Anticoagulated Patients: 2-Year Results of the LEADERS FREE Oral Anticoagulation Substudy. JACC Cardiovasc Interv. 2017 Aug 28;10(16):1633-1642.

Use of the Instantaneous Wave-free Ratio or Fractional Flow Reserve in PCI. N Engl J Med. 2017 May 11;376(19):1824-1834.

LEADERS FREE Investigators. 2-Year Outcomes of high bleeding risk patients after Polymer-Free Drug-Coated Stents. J Am Coll Cardiol. 2017 Jan 17;69(2):162-171.

Coronary Intervention with the Excimer Laser: Review of the Technology and Outcome Data. Interv Cardiol. 2016 May;11(1):27-32.

 Polymer-free Drug-Coated Coronary Stents in Patients at High Bleeding Risk. N Engl J Med. 2015 Nov 19;373(21):2038-47.

Impact of proctoring on success rates for percutaneous revascularisation of coronary chronic total occlusions. Open Heart. 2015 Mar 28;2(1).

Randomized trial of complete versus lesion-only revascularization in patients undergoing primary percutaneous coronary intervention for STEMI and multivessel disease: the CvLPRIT trial. J Am Coll Cardiol. 2015 Mar 17;65(10):963-72.

Adjunctive strategies in the management of resistant, 'undilatable' coronary lesions after successfully crossing a CTO with a guidewire. Curr Cardiol Rev. 2014 May;10(2):145-57.


Declaration

Dr Suneel Talwar works with the following private medical insurance providers:
  • Aviva Health
  • APRIL
  • AXA PPP Healthcare
  • AXA PPP International
  • Benenden Health
  • Bupa
  • Cigna
  • CS Healthcare
  • Exeter Family Friendly
  • Health-on-Line
  • Simplyhealth
  • Vitality Health (Pru Health)

Dr Suneel Talwar does not hold a share or financial interest in this hospital, another Nuffield Health hospital or the company.

Dr Suneel Talwar does not have a share or financial interest in equipment used at this hospital or another Nuffield Health hospital.

Dr Suneel Talwar does not hold any paid advisory role(s) at this hospital or on behalf of Nuffield Health.